|Day Low/High||412.25 / 428.09|
|52 Wk Low/High||176.42 / 433.58|
The CRM software giant sports relatively low sales and billings multiples, and it stands to benefit in several ways from COVID's impact on enterprise tech adoption.
I just wish that people knew more about themselves and took the education necessary to understand what can wrong.
I'm not impressed by the markets' moves and they could easily foil even the best plans -- but here's how to position yourself.
Palantir is likely to get a lot of questions about its cost structure, and perhaps also about the sustainability of recent growth rates.
The company's backlog of revenue set to be recognized in the next 12 months grew much more strongly than expected.
Instead of scratching your head and saying the market defies logic, look to the Cramer Covid-19 Index.
The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.
While some growth stocks have been bid up to extreme valuations, others could look intriguing if markets see a meaningful downturn.
Here's how to approach Atlassian as the strong market has benefited the name.
I don't have a cute acronym, but I guess we could say this is the GPS to find relative value.
SMAR is one of the few names not releasing earnings right now, and appears an attractive play.
This is a lower probability trade, but with the coiled price action around BA, it wouldn't take much to spring this one to life.
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
Despite the dramatic and highly negative decline in economic activity that forced algos to hit the markets from above, enough portfolio managers faded that move to lessen its impact.
Things will be different after Covid-19 and one change will be in how people care about themselves.
I would not rule out the risk of a decline.
After this past week of market insanity, let's explore Micron Technology, Advanced Micro Devices, Atlassian and Energy Select Sector SPDR.
As the Wuhan coronavirus shakes up the global economy and growth outlook for China, there seems to be only one theme that's resonating right now.
Valuations for many enterprise software firms remain rich. But like chip companies, their earnings reports generally haven't done much to spoil the fun.
Many market players - including me - would be relieved to see a decent bout of selling.
The market impact of the virus for U.S. investors has been seen in more pronounced fashion in Treasury markets.
As many software and cloud names come to life, TEAM is no different.
This stock may have hit a short-term bottom and be ready to bounce.
During a talk with TheStreet, long-time Smartsheet CEO Mark Mader argued his firm's workflow automation platform still has a lot of headroom to displace manual business processes.
In the market cap bracket between $5 billion and $100 billion sit some of the most egregiously overvalued, economically inefficient bubble stocks in this peaking market.
Is there room for three names in the workplace communication sector?
With Microsoft, I'm most interested in the advancement of Microsoft Teams, a dominant force in the workplace communication space.